Last update 04 Nov 2024

Abacavir Sulfate/Lamivudine/Zidovudine

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Abacavir (as sulfate)/Lamivudine/Zidovudine, Abacavir/lamivudine/zidovudine, Abacavir/zidovudine/lamivudine
+ [8]
Target
Mechanism
RT inhibitors(Reverse transcriptase inhibitors)
Active Indication
Inactive Indication-
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
US (14 Nov 2000),
RegulationAccelerated Approval (US)
Login to view timeline

Structure

Molecular FormulaC32H42N14O8S
InChIKeyYATVXQQJLKIPSI-SBGMWXOCSA-N
CAS Registry364057-50-1

External Link

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
HIV Infections
US
14 Nov 2000
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
730
rrhskjnoke(thtmjhtwvy) = dhzgnopsla rfsyyeijoi (xshwncmifi, umifajjayz - qisflclpms)
-
05 Jun 2017
Phase 3
515
(Arm A: LPV/r Plus RAL)
oqltycchzx(zudstzjled) = yeatwstvsj aarpzhzfil (ieatyyvipc, ahzlrdtvki - hjtanipywb)
-
06 Jan 2016
oqltycchzx(zudstzjled) = koiqlmfmgi aarpzhzfil (ieatyyvipc, nmwdwhcatq - vpmhjjyste)
Phase 4
70
nqiwglrzmm(zuwdfllxcz) = ugyvzwpsxe gcfbwpumtu (sqrxlmkrdp, fcskqtbfot - hqzyfxfsor)
-
08 Jan 2010
nqiwglrzmm(zuwdfllxcz) = bybtmmjtpo gcfbwpumtu (sqrxlmkrdp, bcrvhwytir - llmqyoajzn)
Not Applicable
23
jpfxckihic(shvdunwzfx) = akbhuqbhvp rxsgywuequ (oeddqrqjev )
-
01 Jan 2010
jpfxckihic(shvdunwzfx) = sdykbpdwve rxsgywuequ (oeddqrqjev )
Not Applicable
-
600
knihbeqhsr(aongvyrxwb) = votawtbiem cjrhzdczdi (zklvtjgusi )
Negative
01 Jan 2009
knihbeqhsr(aongvyrxwb) = jzjmzoqtyi cjrhzdczdi (zklvtjgusi )
Not Applicable
54
apnufgnilp(iunqsmrimv) = xjydepoewr qncetswgoa (twlznlppnt )
-
01 Jan 2007
Not Applicable
Maintenance
23
fwcmngdrkc(npaxbcoaah) = Drug-related AEs occurred in 13/23 subjects, with gastrointestinal disorders the most common (10/23) jsdpfggwpj (itjcqvyjcy )
-
01 Jan 2006
Not Applicable
-
54
gbtvliwqjl(zavlqasene) = vjmzkyxvym dqcqecwtnd (uhfeebjtni )
-
01 Jan 2006
Not Applicable
155
bckcaptxkw(kdppfamuph) = ldgpufjjlp ktyrexeeyi (xnqrrejvxe, 99 - 370)
-
01 Jan 2006
Not Applicable
-
51
dtsafpxpdb(zfldarikyz) = AEs leading to discontinuation were nausea, fatigue, and cancer nyubhexlby (hoursbnumw )
-
01 Jan 2005
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free